HAE Haemonetics PE ratio, current and historical analysis
As of Nov 21, 2024, the HAE stock has a PE ratio of 35.16. The calculation is based on the latest EPS of $2.43 and the stock price of $85.43 per share. The PE ratio currently is comparable to its last four-quarter average.
HAE PE ratio history
The mean historical PE ratio of Haemonetics over the last ten years is 109.37. The current 35.16 P/E ratio is 68% lower than the historical average. Looking back at the last ten years, HAE's PE ratio peaked in the Sep 2017 quarter at 641, with a price of $44.87 and an EPS of $0.07. The Jul 2023 quarter marked the lowest point at 31.65, with a price of $85.14 and an EPS of $2.69.
Haemonetics PE ratio by year
Maximum annual increase: 183.71% in 2015
Maximum annual decrease: -51.48% in 2023
| Year | PE ratio | Change |
|---|---|---|
| 2024 | 36.79 | 0.93% |
| 2023 | 36.45 | -51.48% |
| 2022 | 75.12 | 5.27% |
| 2021 | 71.36 | 6.75% |
| 2020 | 66.85 | -18.24% |
| 2019 | 81.76 | -3.89% |
| 2018 | 85.07 | N/A |
| 2017 | N/A | N/A |
| 2016 | N/A | N/A |
| 2015 | 133.97 | 183.71% |
HAE average PE ratio chart
The current PE ratio of HAE is lower than its 3, 5 and 10-year averages.
HAE PE vs peers
In comparison to its peers SYK and BDX, HAE's PE ratio is lower, but it is higher than JNJ's and TMO's. Haemonetics's current PE ratio of 35.16 is similar to the average of its peers, which is 34.87.
| Stock name | PE ratio | Market cap |
|---|---|---|
| JNJ Johnson & Johnson | 25.79 | $374.39B |
| MDT Medtronic plc | 28.44 | $108.68B |
| TMO Thermo Fisher Scientific Inc | 32.28 | $197.41B |
| HAE Haemonetics Corp | 35.16 | $4.29B |
| SYK Stryker Corp | 41.37 | $148.73B |
| BDX Becton Dickinson & Co | 46.48 | $65.16B |
| BAX Baxter International Inc | 157.1 | $16.84B |
| CERS Cerus Corp | N/A | $310.14M |
Frequently asked questions
What is Haemonetics's PE ratio?
As of Nov 21, 2024, HAE stock has a price to earnings ratio of 35.16.
What is the 3-year average PE ratio for Haemonetics (HAE)?
The 3-year average price to earnings ratio for HAE stock is 48.28.
What is the 5-year average PE ratio for Haemonetics (HAE)?
The 5-year average price to earnings ratio for HAE stock is 55.26.
What is the highest PE ratio for HAE?
Over the last ten years, the quarterly PE ratio reached its highest level at 641 in the Sep 2017 quarter.
How does the current PE ratio for HAE compare to its historical average?
HAE's current price to earnings ratio is 68% below its 10-year historical average.
How is HAE's PE ratio calculated (Haemonetics PE ratio formula)?
To determine the P/E ratio, divide the latest stock price by the TTM earnings per share (EPS). As of today (Nov 21, 2024), Haemonetics's share price is $85.43. The company's earnings per share for the trailing twelve months (TTM) ending Sep 2024 is $2.43. Therefore, Haemonetics's PE ratio for today is 35.16. PE RATIO(35.16) = STOCK PRICE($85.43) / TTM EPS($2.43)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified. Data from 
and Sharadar.